Welcome Visitor Sunday, November 24, 2024

Articles related to Holden Capital


BioMimetic shakes-off FDA bruise,<Br> carves-out Biotechnology niche
BioMimetic shakes-off FDA bruise,
carves-out Biotechnology niche

Now, after selling its first FDA-approved product to a close ally, BioMimetic is flush with cash and experience -- and committed to developing biotechnologies in Middle Tennessee.

Read More

Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: